Table 2.
Reference, Publication Year, Animal Species, Polyphenol(s), and Dosage | Major Physiological Issues Improved | Mode of Action | |
---|---|---|---|
Antioxidative and Anti-Inflammatory Action | Gut Microbiota Modulation | ||
[56] 2017 Mice, chlorogenic acid (CA), p.o. with drinking water containing 1 mM CA for 15 days; 2.5% DSS was given during the last 8 days with CA |
Ameliorated DSS-induced colitis and improved mucosal damage | Suppressed the active NF-κB signaling pathway in the colon | Decreased the Firmicutes/Bacteroidetes ratio and increased the relative abundance of Akkermansia |
[57] 2017 Mice, nanoparticle curcumin (NC), p.o. with diet containing 0.2% NC for 18 days; 3% DSS was given from day 8 to day 18 |
Ameliorated DSS-induced colitis and improved mucosal permeability | Suppressed NF-κB activation in colonic epithelial cells | Increased the abundance of butyrate-producing bacteria and fecal butyrate levels |
[58] 2018 Mice, bronze tomato extract (BTE) rich in anthocyanins, flavonols, and stilbenoids, p.o. with diet containing 1% BTE for 2 weeks; 1% DSS was given from day 14 to day 29 |
Ameliorated DSS-induced colitis | Suppressed LPS-mediated production of pro-inflammatory cytokines | Decreased the Firmicutes/Bacteroidetes ratio |
[59] 2018 Rats, polyphenol-rich Chinese propolis (CP) or Brazilian propolis (BP), p.o. at 300 mg/kg/day for 17 days; 3% DSS was given from day 7 for 1 week |
Ameliorated DSS-induced colitis | Alleviated the intestinal oxidative status, and suppressed inflammatory gene expression in the distal colon | Reduced populations of Bacteroides spp. |
[60] 2018 Mice, quercetin aglycone (Q) or quercetin aglycone with monoglycosides (Q + MQ), p.o. with diet containing 0.21% Q or 0.35% Q + MQ for 7 days; 3% DSS was given from day 8 for 1 week |
Ameliorated DSS-induced colitis | Suppressed oxidative stress indicated by MPO, GSH, and MDA | Ameliorated reduced Firmicutes population and increased Proteobacteria population by DSS |
[61] 2019 Mice, rape bee pollen extract rich in polyphenols including kaempferol, sinapic acid, and rosmarinic acid, p.o. at 10.6 and 21.2 g/kg/day for 15 days; 3% DSS was given from day 8 to day 12 |
Ameliorated DSS-induced colitis | Attenuated oxidative stress and downregulated the expression of inflammatory cytokines such as IL-1β | Reduced the abundance of Allobaculum and Bacteroides, and increased the abundance of Lactobacillus |
[62] 2019 Rats, honey polyphenols including caffeic acid, chlorogenic acid, and rutin, p.o. at 10.5 mg/kg twice daily for 7 days; 3% DSS was given from day 0 to day 5 |
Improved DSS-induced colonic apoptosis and reduced the expression of inflammatory cytokines in the colon | Improved the levels of SOD, GSH-Px, NO, and MPO; downregulated the expression of IL-1β, IL-6, TNF-α, and IFN-γ genes, and upregulated the expression of IκB-α gene | Reduced the population of Bacteroides, Corynebacterium, and Proteus species at the genus level |
[63] 2021 Mice, taxifolin, p.o. at 100 mg/kg/day for 7 days; from day 8, mice received 3% DSS for 7 days |
Prevented DSS-induced colitis | Inhibited the secretion of proinflammatory cytokines, and increased the secretion of IL-10, secretory IgA, SOD, and immunoglobulins; increased the expression of intestinal tight junction proteins | Restored the microbiota composition in the colon, including the decrease in the abundance of Bacteroidetes and the Bacteroidetes/Firmicutes ratio at the phylum level |
[64] 2021 Mice, Exp. I, epigallocatechin-3-gallate (EGCG), p.o. or rectal administration at 50 mg/kg/day for 3 days starting after supplementation with 2.5% DSS for 7 days; Exp. II, EGCG, p.o. at 50 mg/kg/day for 3 weeks with 2.5% DSS for the last 6 days; Exp. III, 2.5% DSS for 7 days followed by FMT for 3 days |
Exp. I: oral, but not rectal, EGCG alleviated DSS-induced colitis; Exp. II: oral EGCG prevented DSS-induced colitis; Exp. III: FMT alleviated DSS-induced colitis |
Oral, but not rectal, EGCG attenuated oxidative stress, and exerted an anti-inflammatory effect along with enhanced integrity of the colonic barrier; oral EGCG pre-supplementation induced beneficial outcomes similar to those achieved with oral EGCG administration | Attenuation of colitis by oral EGCG suggests an intimate involvement of SCFA-producing bacteria, of the genus Akkermansia. |
[65] 2021 Mice, green pea (Pisum sativum L.) hull polyphenol extracts containing quercetin and its derivatives, kaempferol trihexanside, and catechin and its derivatives, p.o. at 100 and 600 mg/kg for 14 days; 3% DSS was given for 7 weeks from day 8 |
Alleviated DSS induced colitis | Restored oxidative balance, and regulated inflammatory factors along with repaired colonic function | Increased the Firmicutes/Bacteroidetes ratio, promoted the growth of Lactobacillaceae and Lachnospiraceae, and improved the level of SCFAs |
p.o., per os; IL-1β, interleukin-1β; SOD, superoxide dismutase; GSH-Px, glutathione peroxidase; NO, nitric oxide; IL-6, interleukin-6; TNF-α, tumor necrosis factor-α; IFN-γ, interferon-γ; IκB-α, NF-κB inhibitor-α; IL-10, interleukin-10; IgA, immunoglobulin A; FMT, fecal microbiota transplantation; SCFA, short-chain fatty acids.